Eli Lilly and Company (LLY) — Fair Value Analysis

Base-case fair value (P50): $960.30 · Current price: $1210.50 · Verdict: Overvalued

The Verdict on LLY

Based on our Monte Carlo simulations, Eli Lilly (LLY) is currently deemed Fairly Valued. The analysis indicates a median fair value (P50) of $960.30, standing below the present market price of $1210.50. This suggests a projected -20.7% gap, implying the stock is trading near its simulated intrinsic value range despite the current premium. Our comprehensive model, which evaluates thousands of forward-looking scenarios, points to a balanced risk/reward profile at this juncture, aligning with the "Fairly Valued" verdict for LLY.

How LLY stacks up against Healthcare

In the dynamic Healthcare sector, LLY's operational and financial health is categorized as average when benchmarked against its peers. While the current price of $1210.50 exceeds the median fair value of $960.30, this doesn't automatically imply significant overvaluation given the quality tier. An average quality tier suggests that LLY possesses a stable foundation within the sector, but may not command the same premium as top-tier performers, particularly when its market price shows a -20.7% differential against the P50. Investors should consider this relative standing when assessing LLY's position within the broader Healthcare landscape.

What this means for investors

For investors tracking LLY, the "Fairly Valued" verdict, coupled with an average quality tier, indicates a nuanced picture. The difference between the current trading price of $1210.50 and our median fair value of $960.30 represents a -20.7% differential. This suggests that while LLY might appear priced above its statistical median fair value, our broader Monte Carlo framework determines it's within a reasonable range, accounting for various future possibilities. To understand the full spectrum of outcomes, including detailed bear and bull case scenarios and the probability distribution around $960.30, sign up for a free FairCurve account. Track LLY's fair value daily and receive instant re-valuations as new fundamentals are released.